Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 16, 2024
Abstract
Acute
kidney
injury
(AKI)
is
a
prevalent
clinical
syndrome
with
high
morbidity
and
mortality.
Accumulating
studies
suggest
mitochondrial
dysfunction
as
the
typical
characteristics
key
process
of
AKI,
but
underlying
mechanism
remains
elusive.
The
YME1‐like
1
(YME1L1)
ATPase,
an
inner
membrane
protein,
screened
identified
to
be
downregulated
in
renal
tubular
epithelial
cells
various
mouse
models
patients
AKI.
Dramatically,
restoration
YME1L1
expression
significantly
alleviates
cisplatin‐induced
AKI
subsequent
chronic
disease
(CKD)
through
attenuating
via
maintaining
optic
atrophy
(OPA1)‐mediated
energy
metabolism
homeostasis.
Mechanistically,
upregulated
sterol
regulatory
element
binding
transcription
factor
1c
(SREBP1c)
demonstrated
responsible
for
cisplatin‐mediated
transcriptional
inhibition
directly
its
promoter
region.
Moreover,
methyltransferase‐like
3
(METTL3)‐mediated
m6A
modification
enhances
SREBP1c
mRNA
stability,
thereby
upregulating
expression.
Notably,
both
depletion
tubule‐specific
overexpression
markedly
ameliorate
transition
CKD.
Taken
together,
these
findings
that
METTL3‐mediated
upregulation
contributes
progression
CKD
disrupting
transcriptionally
suppressing
YME1L1.
Targeting
SREBP1c/YME1L1
signaling
may
serve
novel
therapeutic
strategy
against
Abstract
Background
Aberrant
mitochondrial
fission,
a
critical
pathological
event
underlying
myocardial
ischemia/reperfusion
(MI/R)
injury,
has
emerged
as
potential
therapeutic
target.
The
long
non-coding
RNA
(lncRNA)
Oip5-as1
is
increasingly
recognized
for
its
regulatory
roles,
particularly
in
MI/R
injury.
However,
precise
mechanistic
role
modulating
dynamics
remains
elusive.
This
study
aims
to
elucidate
the
of
regulating
fission
and
evaluate
against
Methods
To
simulate
vitro
HL-1
cardiomyocytes
were
subjected
hypoxia/reoxygenation
(H/R).
Lentiviral
vectors
employed
achieve
overexpression
or
knockdown
cells
by
expressing
shRNA
targeting
Oip5-as1,
respectively.
impact
on
was
assessed
using
CCK-8
assay,
flow
cytometry,
immunofluorescence
staining,
biochemical
assays.
injury
induced
mice
ligating
left
anterior
descending
coronary
artery.
Conditional
knockout
generated
CRISPR/Cas9
genome
editing
technology,
while
achieved
via
intramyocardial
administration
AAV9
vectors.
In
mice,
evaluated
through
echocardiographic
assessment,
histopathological
transmission
electron
microscopy.
Furthermore,
Western
blotting,
pull-down,
immunoprecipitation,
co-immunoprecipitation
assays
conducted
investigate
Oip5-as1’s
mechanisms.
Results
expression
levels
are
significantly
decreased
MI/R-injured
myocardium.
undergoing
H/R
attenuated
excessive
preserved
functionality,
reduced
cellular
apoptosis,
exhibited
opposite
effects.
mouse
model
diminished
infarct
size
improved
cardiac
function.
exacerbated
dysfunction,
which
reversed
treatment
with
division
inhibitor-1
(Mdivi-1).
Mechanistically,
selectively
interacts
AKAP1
CaN
proteins,
inhibiting
activation
subsequent
DRP1
dephosphorylation
at
Ser637,
thereby
constraining
DRP1’s
translocation
mitochondria
involvement
fission.
Conclusions
Our
underscores
pivotal
mitigating
during
findings
not
only
enhance
our
comprehension
molecular
mechanisms
but
also
identify
target
ameliorating
Graphical
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
206, P. 107250 - 107250
Published: June 13, 2024
Dynamin-related
protein
1
(DRP1)
is
an
essential
controller
of
mitochondrial
fission
whose
activity
tightly
controlled
to
ensure
balanced
dynamics
and
maintain
internal
cellular
homeostasis.
Growing
evidence
suggests
that
DRP1-dependent
plays
a
role
in
drug-induced
toxicity
(DIT).
Therefore,
understanding
the
molecular
mechanisms
underlying
DIT
precise
regulation
DRP1
function
will
inform
development
potential
therapeutic
treatments
for
DIT.
This
review
comprehensively
summarizes
diverse
DITs
their
mechanism
associated
with
discusses
vivo
vitro
model
studies
protection
targeting
DRP1.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 1955 - 1955
Published: Feb. 24, 2025
Mitochondria
are
dynamic
organelles
that
play
crucial
roles
in
energy
production,
metabolic
balance,
calcium
homeostasis,
apoptosis,
and
innate
immunity,
key
determinants
of
cell
fate.
They
also
targets
for
viral
invasion
the
body.
Many
proteins
target
mitochondria,
controlling
mitochondrial
morphology,
metabolism,
immune
response,
thereby
achieving
evasion,
promoting
their
proliferation,
accelerating
infection
process.
Mitochondrial
quality
control
is
to
maintaining
normal
physiological
functions
homeostasis.
Dysregulation
dynamics
closely
related
development
many
diseases.
New
constantly
being
discovered.
Viruses
change
by
targeting
mitochondria
achieve
a
persistent
state
infection.
Currently,
understanding
during
limited.
Research
on
impact
provides
foundation
investigating
pathogenesis
infections,
disease
process,
identifying
potential
therapeutic
targets.
This
review
focuses
connection
between
priority
areas
research
virus-mediated
insight
into
regulation
viruses
explores
means
mitochondrial-mediated
treatment
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 12, 2025
Renal
fibrosis
and
vascular
rarefaction
are
significant
complications
of
ischemia/reperfusion
(I/R)
injury.
Human
umbilical
cord
mesenchymal
cell-derived
exosomes
(hucMSC-exos)
have
shown
potential
in
mitigating
these
conditions.
This
study
investigates
the
role
miR-29a-3p
its
therapeutic
effects
on
I/R-induced
renal
damage.
Male
C57BL/6
mice
were
subjected
to
unilateral
ischemia
for
28
min
followed
by
reperfusion.
Exosomes
mimics/inhibitors
injected
into
mice.
function,
histological
analysis,
molecular
assays
performed
evaluate
integrity.
Exosome
treatment
significantly
improved
function
reduced
post-I/R.
MiR-29a-3p
was
highly
expressed
hucMSC-exos
but
models.
mimic
reduced,
while
inhibitor
exacerbated
rarefaction.
Collagen
I
TNFR1
identified
as
direct
targets
fibroblasts
endothelial
cells,
respectively.
overexpressing
provided
superior
protection
compared
unmodified
hucMSC-exos.
HucMSC-exos,
particularly
those
miR-29a-3p,
potent
against
collagen
I,
highlighting
therapy.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: March 19, 2025
Abstract
Nucleic
acids
from
both
self-
and
non-self-sources
act
as
vital
danger
signals
that
trigger
immune
responses.
Critical
illnesses
such
acute
respiratory
distress
syndrome,
sepsis,
trauma
ischemia
lead
to
the
aberrant
cytosolic
accumulation
massive
release
of
nucleic
are
detected
by
antiviral
innate
receptors
in
endosome
or
cytosol.
Activation
for
deoxyribonucleic
ribonucleic
triggers
inflammation,
a
major
contributor
morbidity
mortality
critically
ill
patients.
In
past
decade,
there
has
been
growing
recognition
therapeutic
potential
targeting
acid
sensing
critical
care.
This
review
summarizes
current
knowledge
ischemia.
Given
extensive
research
on
common
pathological
conditions
like
cancer,
autoimmune
disorders,
metabolic
disorders
aging,
we
provide
comprehensive
summary
beyond
illness
offer
insights
may
inform
its
role
conditions.
Additionally,
discuss
strategies
specifically
target
sensing.
By
examining
sources,
sensor
activation
function,
well
impact
regulating
these
pathways
across
various
diseases,
highlight
driving
illness.